Mostrar el registro sencillo del ítem

dc.creatorBeishon L., Woodhouse L.J., Bereczki D., Christensen H.K., Collins R., Gommans J., Kruuse C., Ntaios G., Ozturk S., Phillips S., Pocock S., Szatmari S., Wardlaw J., Sprigg N., Bath P.M.en
dc.date.accessioned2023-01-31T07:37:19Z
dc.date.available2023-01-31T07:37:19Z
dc.date.issued2021
dc.identifier10.1136/svn-2020-000498
dc.identifier.issn20598688
dc.identifier.urihttp://hdl.handle.net/11615/71352
dc.description.abstractIntroduction Nitrate-induced headache is common and may signify responsive cerebral vasculature. We assessed the relationship between nitrate headache and outcome in patients with acute stroke. Materials and methods Patients were those randomised to glyceryl trinitrate (GTN) versus no GTN in the efficacy of nitric oxide in stroke trial. Development of headache by end of treatment (day 7), and functional outcome (modified Rankin Scale, primary outcome) at day 90, were assessed. Analyses are adjusted for baseline prognostic factors and give OR and mean difference (MD) with 95% CI. Results In 4011 patients, headache was more common in GTN than control (360, 18.0% vs 170, 8.5%; p<0.001). Nitrate-related headache was associated with: younger age, female sex, higher diastolic blood pressure, non-total anterior circulation syndrome, milder stroke and absence of dysphasia (p<0.05). Nitrate headache was not associated with improved functional outcome (OR 0.90, 95% CI 0.73 to 1.10, p=0.30) or death (day 90) (HR 0.64, 95% CI 0.40 to 1.02, p=0.062), but reduced death or deterioration (day 7) (OR 0.45, 95% CI 0.25 to 0.82), death in hospital (OR 0.44, 95% CI 0.22 to 0.88) and improved activities of daily living (Barthel index, MD 3.7, 95% CI 0.3 to 7.1) and cognition (telephone interview cognitive screen, MD 2.0, 95% CI 0.7 to 3.3) (day 90). Non-nitrate headache was not associated with death, disability or cognition. Discussion and conclusion Development of a nitrate headache by day 7 after stroke may be associated with improved activities of daily living and cognitive impairment at day 90, which was not seen with non-nitrate headache. © 2021 BMJ Publishing Group. All rights reserved.en
dc.language.isoenen
dc.sourceStroke and Vascular Neurologyen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85095819081&doi=10.1136%2fsvn-2020-000498&partnerID=40&md5=522d034e37054855c1afd01ea7215c5c
dc.subjectglyceryl trinitrateen
dc.subjectnitrateen
dc.subjectnitric oxideen
dc.subjectnitric acid derivativeen
dc.subjectvasodilator agenten
dc.subjectageden
dc.subjectArticleen
dc.subjectBarthel indexen
dc.subjectbrain hemorrhageen
dc.subjectcerebrovascular accidenten
dc.subjectcognitionen
dc.subjectcontrolled studyen
dc.subjectdaily life activityen
dc.subjectdeteriorationen
dc.subjectdiastolic blood pressureen
dc.subjectdisabilityen
dc.subjectdrug efficacyen
dc.subjectdysphasiaen
dc.subjectfemaleen
dc.subjectheadacheen
dc.subjectheart rateen
dc.subjecthumanen
dc.subjectischemic strokeen
dc.subjectmajor clinical studyen
dc.subjectmaleen
dc.subjectoutcome assessmenten
dc.subjectprognosisen
dc.subjectrandomized controlled trialen
dc.subjectRankin scaleen
dc.subjectstroke patienten
dc.subjectsystolic blood pressureen
dc.subjecttelephone interviewen
dc.subjectcerebrovascular accidenten
dc.subjectheadacheen
dc.subjecttreatment outcomeen
dc.subjectActivities of Daily Livingen
dc.subjectFemaleen
dc.subjectHeadacheen
dc.subjectHumansen
dc.subjectNitratesen
dc.subjectNitric Oxideen
dc.subjectStrokeen
dc.subjectTreatment Outcomeen
dc.subjectVasodilator Agentsen
dc.subjectBMJ Publishing Groupen
dc.titleRelationship between nitrate headache and outcome in patients with acute stroke: Results from the efficacy of nitric oxide in stroke (ENOS) trialen
dc.typejournalArticleen


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem